TNFAIP8 and Miyoshi myopathy: Moreover, miR-155 enhanced the sensitivity of drug-resistant MM cells to Bortezomib through targeting Tumor Necrosis Factor Alpha Induced Protein 8 (TNFAIP8), an oncoprotein which negatively inhibits apoptosis [156].